Cgmp Regulations

FDA
Manufacturing

FDA slaps Aurobindo with warning letter on API testing failures

The FDA slapped Aurobindo Pharma with a warning letter for failing to adequately investigate batch failures of APIs and inadequate evaluations.
by Joseph Keenan
Hammer

FDA hammers another Aurobindo plant for flawed data integrity

Jun 12, 2019 10:11am
Chongqing China

Fosun Pharma accused of ‘massively’ faking production data

Aug 31, 2018 11:03am
EU flag depature

Regulators again pull EuropharmaDK’s manufacturing authorization

Nov 8, 2017 11:45am
FDA

FDA hits China’s Foshan Flying Medical with warning letter

Aug 17, 2017 8:15am
cosmetics bottles

China facility of Ausmetics hit with FDA warning letter

Feb 15, 2017 2:51pm